Renal Sinus Fat Volume on Ct scan: Correlation with Essential Hypertension at Middle-Age Group
DOI:
https://doi.org/10.56056/Keywords:
Adipose tissue, Renal sinus, Essential hypertension, Ellipsoid equationAbstract
Background and objectives: High blood pressure is a major public health problem related to the risk of heart disease, stroke and early death. The aim of this study is to examine the correlation between renal sinus fat volume and hypertension for participation in the future management of hypertension. It could be used as screening parameter for hypertension or decreasing renal sins fat volume as treatment of hypertension.
Methods: This study was an observational cross-sectional implemented in the Rizgary teaching hospital/radiology department- Erbil City-Kurdistan region/Iraq, in a period between February. 2023 till November.2023. The participants were 98 visitors (referred by physicians for diagnoses of other medical issues), divided into hypertensive and non-hypertensive patients. Native abdominal CT scans were captured and by ellipsoid equation the renal sinus volume of each kidney was measured. Renal sinus volumes in each group were evaluated and compared.
Result: The average size of renal sinus fat in left and right kidneys of hypertensive patients was 4.5814 ± 1.088 cm3 and 3.3802 ± 1.02547 cm3 respectively and in control group it was 3.8010 ± 1.10739 cm3 and 2.8004 ± 1.14657 cm3 respectively, it is significantly higher in patients with high blood pressure. There is a significant relationship between the presence of hypertension and renal sinus fat, more at the left kidney (P<0.001). Also, there is a clear difference in size of the renal sinus according to sex.
Conclusion: Increased volume of renal sinus in middle-aged persons with essential hypertension, suggesting that there is a pathophysiological mechanism causing increasing volume of renal sinus fat in hypertensive people.
Downloads
References
1. GBD 2017 Risk Factor Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018 Nov 10;392(10159):1923-1994. doi: 10.1016/S0140-6736(18)32225-6. Epub 2018 Nov 8.
2. Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 international society of hypertension global hypertension practice guidelines. J Hypertens. 2020 Jun;38(6):982-1004. doi: 10.1097/HJH.0000000000002453/
3. Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018 Sep 1;39(33):3021-3104. doi: 10.1093/eurheartj/ehy339/
4. Poulter NR, Prabhakaran D, Caulfield M. Hypertension. Lancet. 2015 Aug 22;386(9995):801-12. doi: 10.1016/S0140-6736(14)61468-9. Epub 2015 Mar 29.
5. Donatas Austys,1, Andrej Dobrovolskij,2,3 Valerija Jablonskien?,4 Valerij Dobrovolskij,1 Nomeda Valevi?ien?,2 and Rimantas Stukas1. Medicina (Kaunas). 2019 Aug; 55(8): 456. doi: 10.3390/medicina55080456/
6. Ye RZ, Richard G, Gévry N, Tchernof A, Carpentier AC. Fat Cell Size: Measurement Methods, Pathophysiological Origins, and Relationships with Metabolic Dysregulations. Endocr Rev. 2022 Jan 12;43(1):35-60. doi: 10.1210/endrev/bnab018/
7. Qatanani M, Lazar MA. Mechanisms of obesity-associated insulin resistance: many choices on the menu. Genes Dev. 2007 Jun 15;21(12):1443-55. doi: 10.1101/gad.1550907/
8. Thomou T, Tchkonia T, Kirkland JL. Cellular and molecular basis of functional differences among fat depots. In: Leff TA, Granneman JG, editors. Adipose Tissue in Health and Disease. Wiley-VCH; Weinheim, Germany: 2010: 21–47.
9. Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu CY, et al. Abdominal, visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation. 2007 Jul 3;116(1):39-48. doi:10.1161/CIRCULATIONAHA.106.675355. Epub 2007 Jun 18.
10. Sironi AM, Gastaldelli A, Mari A, Ciociaro D, Positano V, Buzzigoli E, et al. Visceral fat in hypertension: influence on insulin resistance and ?-cell function. Hypertension. 2004 Aug;44(2):127-33. doi: 10.1161/01.HYP.0000137982.10191.0a. Epub 2004 Jul 19.
11. Foster MC, Hwang SJ, Porter SA, Massaro JM, Hoffmann U, Fox CS. Development and reproducibility of a computed tomography-based measurement of renal sinus fat. BMC Nephrol. 2011 Oct 4:12:52. doi: 10.1186/1471-2369-12-52/
12. Montani JP, Carroll JF, Dwyer TM, Antic V, Yang Z, Dulloo AG. Ectopic fat storage in heart, blood vessels and kidneys in the pathogenesis of cardiovascular diseases. Int J Obes Relat Metab Disord. 2004 Dec:28 Suppl 4: S58-65. doi: 10.1038/sj.ijo.0802858/
13. Dwyer TM, Mizelle HL, Cockrell K, Buhner P. Renal sinus lipomatosis and body composition in hypertensive, obese rabbits. Int J Obes Relat Metab Disord. 1995 Dec;19(12):869-74.
14. M.H. Fonseca-Alaniz, J. Takada, M.I.C. Alonso-Vale, F.B. Lima. The adipose tissue as a regulatory center of the metabolism. Arq Bras Endocrinol Metabol. 2006 Apr;50(2):216-29. doi: 10.1590/s0004-27302006000200008. Epub 2006 May 23.
15. Breau RH, Clark E, Bruner B, Cervini P, Atwell T, Knoll G, Leibovich BC. A simple method to estimate renal volume from computed tomography. Can Urol Assoc J. 2013 May-Jun;7(5-6):189-92. doi: 10.5489/cuaj.1338/
16. Rha SE, Byun JY, Jung SE, Oh SN, Choi YJ, Lee JM. The renal sinus: pathologic spectrum and multimodality imaging approach. Radiographics. 2004 Oct:24 Suppl 1: S117-31. doi: 10.1148/rg.24si045503/
17. Spit KA, Muskiet MHA, Tonneijck L, Smits MM, Kramer HHM, Joles JA. et al. Renal sinus fat and renal hemodynamics: a cross-sectional analysis. MAGMA. 2020 Feb;33(1):73-80. doi: 10.1007/s10334-019-00773-z. Epub 2019 Aug 31.
18. 18. Foster MC, Hwang SJ, Porter SA, Massaro JM, Hoffmann U, Fox CS. Fatty kidney, hypertension, and chronic kidney disease: the Framingham Heart Study. Hypertension. 2011 Nov;58(5):784-90. doi: 10.1161/HYPERTENSIONAHA.111.175315. Epub 2011 Sep 19.
19. 19. Dwyer TM, Mizelle HL, Cockrell K, Buhner P. Renal sinus lipomatosis and body composition in hypertensive, obese rabbits. Int J Obes Relat Metab Disord. 1995 Dec;19(12):869-74.
20. 20. Tonelli M, Moyé L, Sacks FM, Cole T, Curban G C; Cholesterol and recurrent events trial investigators. Effect of pravastatin on loss of renal function in people with moderate chronic renal insufficiency and cardiovascular disease. J Am Soc Nephrol. 2003 Jun;14(6):1605-13. doi: 10.1097/01.asn.0000068461.45784.2f.ase. J Am Soc Nephrol. 2003; 14(6): 1605–1613. OI.
21. 21. Caglar V, Songur A, Acar M, Uygur R, Alkoc OA, Acar T. Volumetric evaluation of fat in the renal sinus in normal subjects using stereological method on computed tomography images and its relationship with body composition. Folia Morphol (Warsz). 2014 Aug;73(3):302-8. doi: 10.5603/FM.2014.0016/
22. 22. Raphael H, Klang E, Konen E, Inbar Y, Leibowitz A, Frenkel-Nir Y. et al. Obesity Is Associated with Fatty Liver and Fat Changes in the Kidneys in Humans as Assessed by MRI. Nutrients. 2024 May 3;16(9):1387. doi: 10.3390/nu16091387/
23. 23. Cohen EI, Kelly SA, Edye M, Mitty HA, Bromberg JS. MRI estimation of total renal volume demonstrates significant association with healthy donor weight. Eur J Radiol. 2009 Aug;71(2):283-7. doi: 10.1016/j.ejrad.2008.03.006. Epub 2008 Apr 23.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Rebaz Fattah Mahmood, Saeed Nadhim Younis
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The copyright on any article published in AMJ (The Scientific Journal of Kurdistan Higher Council of Medical Specialties )is retained by the author(s) in agreement with the Creative Commons Attribution Non-Commercial ShareAlike License (CC BY-NC-SA 4.0)
